Iluka Res Imini (ILUJOP) Quote

All the shareholders ask for is some disclosure. Being told we will be force fed and they are upset with an investor so nothing will occur as they don’t want that person to profit is a horrible position for a company. Yes, this was posted by someone the other day. Many of us believe in the company w

Thanks B-M $$$IQST$$$$

You're still not understanding the concept of the backstop.

The reason that shareholders will wait until T+3 has nothing to do with me asking them to do so. If the backstop was a $2 buy out, then shareholders are simply not going to sell for less than that because it makes no logical

WCVC - Shareholders' hope the stock will find it's way back.

I am one of those shareholders…..

Uh huh.

Juncture City 57......News Before It Happens

https://investorshub.advfn.com/uimage/uploads/2024/8/8/gpuusBTC_888_8_3M_PLAIN_JUNCTURE.jpg

https://investorshub.advfn.com/uimage/uploads/2024/8/8/vtouwBTC_888_8_1y_3am_57_wedge.jpg

It’s Time for Long-term Investors to Make Money: From Nick’s recent twits, I understand that he will let SNPW run now, which will be ignited by his PRs. The Loyal & Long-term Retail investors got wiped out due to 4000:1 RS & it’s time for them to start making money. Dilution is not a factor now as I

Buy the dip and let it rip

That's an interesting take, but I have an opposite view.

Remember that ERHC loses ALL of its licenses on Sept 30th if not extended. It's not only block 4 but the JDZ too.

There's only ONE way to extend the license per the contract and that one way is by signing an oper

I'm not lying about Questrade.

The guy you talked to at Questrade misinformed you, because you probably didn't ask the question properly. If you have a Questrade account all you have to do is go online and place a buy order and you can buy it. But I prefer Scotia iTrade because they

The treatment is currently outstanding. And utilizes natural immune responses that have been shown in side studies by UCLA to have the ability to be enhanced with an adjuvant. It is normal for yes, vaccines to be further studied with the addition of adjuvants and no, yes, the MHRA just like the FDA

Yeah I forgot about the markets.

micro nasdaqs getting killed...dilute then delist is the pattern...company is toast!

There's dilution. They have an open Reg A at .005....

Are you kidding? Patients are living 20+ years without recurrence. In the phase 3 with the drug alone it doubled patients living beyond 5 years and that just the end of the study. Doesn’t mean they were “dead”.

With poly-iclc as an adjuvant stimulant you had one arm 100% of the patien

its time time to burn these f$cking shorts

what price you thinkin for "U's" ????

Yep, I agree.

https://www.darkreading.com/threat-intelligence/cybersecurity-industry-leaders-launch-the-cyber-threat-intelligence-capability-maturity-model
Wave is, for sure, mature enough, now, so use it!

First look combination combination studies with a TLR agonist leads to 50% over 5 year survival for nGBM. With Keytruda rGBM has led to 60% cure rate.

If you continue to take a myopic view you will lose. Recent Keytruda combo is due to finish this month. Usually these things are neve

Will the dry eye confirmatory P3 trial prove successful this morning? Hard to call, but leaning towards yes.

Yup, but there was a dog eating hw back then.

On top of it all imagine starting 5 trials at the same time, during or a year after a pandemic and in this economic environment lol

Sometimes slow and steady wins the race.

Whether foresight or luck here w

Con men are a dime a dozen

https://www.youtube.com/watch?v=OcAK7EepBVs

https://www.bridgemi.com/michigan-health-watch/michigans-mclaren-health-care-confirms-cyberattack-asks-patience
Patience! That's what we have needed from the internet in waiting for them to use Wave. It is about time...

NOPAIN Act
Jan. 1, 2025

https://www.congress.gov/bill/117th-congress/house-bill/3259/text?s=2&r=1&q=%7B%22search%22%3A%22NOPAIN+ACT%22%7D

Just to highlight a few points::

(G) ACCESS TO NON-OPIOID TREATMENTS FOR PAIN.—
“(i) IN GENERAL.—